Total submissions: 8
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| ARUP Laboratories, |
RCV000851476 | SCV005876314 | likely benign | not provided | 2024-01-26 | criteria provided, single submitter | clinical testing | |
| Hereditary Cancer Group, |
RCV000573620 | SCV005442498 | likely benign | Hereditary cancer-predisposing syndrome | 2024-12-19 | criteria provided, single submitter | clinical testing | BS1, BP4, BP7 |
| Ce |
RCV000851476 | SCV004811097 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | DICER1: BP4, BP7 |
| Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000851476 | SCV004221859 | benign | not provided | 2023-01-31 | criteria provided, single submitter | clinical testing | |
| Sema4, |
RCV000573620 | SCV002533049 | likely benign | Hereditary cancer-predisposing syndrome | 2020-12-23 | criteria provided, single submitter | curation | |
| Prevention |
RCV000851476 | SCV000993764 | likely benign | not provided | 2018-09-12 | criteria provided, single submitter | clinical testing | |
| Ambry Genetics | RCV000573620 | SCV000669330 | likely benign | Hereditary cancer-predisposing syndrome | 2017-11-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
| Labcorp Genetics |
RCV001085715 | SCV000563457 | likely benign | DICER1-related tumor predisposition | 2025-01-01 | criteria provided, single submitter | clinical testing |